Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
Sign Up to like & getrecommendations! Published in 2019 at "Emerging Infectious Diseases"
DOI: 10.3201/eid2507.181200
Abstract: Pseudomonas aeruginosa is intrinsically resistant to many antimicrobial drugs, making carbapenems crucial in clinical management. During July–October 2015 in the United States, we piloted laboratory-based surveillance for carbapenem-resistant P. aeruginosa (CRPA) at sentinel facilities in… read more here.
Keywords: resistant pseudomonas; aeruginosa emerging; pseudomonas aeruginosa; emerging infections ... See more keywords